Global CHA Network

CHA Medical Group

CHA Medical Group’s advanced stem cell technology

CHA Medical Group has filed the following patents related to stem cell and immunocyte research.

No	Patent Grants
61	[CA] Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof (Registration number 002802661)
60	[US] Embryonic stem cell-derived cardiomyocytes and a cellular therapeutic agent comprising the same as an active ingredient (Registration number 10-1849329)
59	[KR] Improved methods of producing RPE cells and compositions of RPE cells (Registration number 10-1849329)
58	[KR] Improved methods of producing RPE cells and compositions of RPE cells (Registration number 10-1849336)
57	[KR] Method for the Isolation and Proliferation of Primary Lung Cancer Cells (Registration number 10-1832133)
56	[KR] Therapeutic composition for skin regeneration and wound healing using CLASP2 (Registration number 10-1799300)
55	[KR] Oral cleansing composition containing granulocyte macrophage-colony stimulating factor (Registration number 10-1771218)
54	[KR] Method for isolating primary mesenchymal stem cells derived from human embryonic stem cells using cell insert culture system (Registration number 10-1760239)
53	[KR] Method for reprogramming cells using nano-carrier and producing induced pluripotent stem cells (Registration number 10-1751957)
52	[KR] Adherent cells from adipose or placenta tissues and use thereof in therapy (Registration number 10-1738323)